Improving Sepsis Outcomes in the Era of Pay-for-Performance and Electronic Quality Measures : A Joint IDSA/ACEP/PIDS/SHEA/SHM/SIDP Position Paper
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com..
The Centers for Medicare & Medicaid Services (CMS) introduced the Severe Sepsis/Septic Shock Management Bundle (SEP-1) as a pay-for-reporting measure in 2015 and is now planning to make it a pay-for-performance measure by incorporating it into the Hospital Value-Based Purchasing Program. This joint IDSA/ACEP/PIDS/SHEA/SHM/SIPD position paper highlights concerns with this change. Multiple studies indicate that SEP-1 implementation was associated with increased broad-spectrum antibiotic use, lactate measurements, and aggressive fluid resuscitation for patients with suspected sepsis but not with decreased mortality rates. Increased focus on SEP-1 risks further diverting attention and resources from more effective measures and comprehensive sepsis care. We recommend retiring SEP-1 rather than using it in a payment model and shifting instead to new sepsis metrics that focus on patient outcomes. CMS is developing a community-onset sepsis 30-day mortality electronic clinical quality measure (eCQM) that is an important step in this direction. The eCQM preliminarily identifies sepsis using systemic inflammatory response syndrome (SIRS) criteria, antibiotic administrations or diagnosis codes for infection or sepsis, and clinical indicators of acute organ dysfunction. We support the eCQM but recommend removing SIRS criteria and diagnosis codes to streamline implementation, decrease variability between hospitals, maintain vigilance for patients with sepsis but without SIRS, and avoid promoting antibiotic use in uninfected patients with SIRS. We further advocate for CMS to harmonize the eCQM with the Centers for Disease Control and Prevention's (CDC) Adult Sepsis Event surveillance metric to promote unity in federal measures, decrease reporting burden for hospitals, and facilitate shared prevention initiatives. These steps will result in a more robust measure that will encourage hospitals to pay more attention to the full breadth of sepsis care, stimulate new innovations in diagnosis and treatment, and ultimately bring us closer to our shared goal of improving outcomes for patients.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:78 |
---|---|
Enthalten in: |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 78(2024), 3 vom: 20. März, Seite 505-513 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Rhee, Chanu [VerfasserIn] |
---|
Links: |
---|
Themen: |
Anti-Bacterial Agents |
---|
Anmerkungen: |
Date Completed 22.03.2024 Date Revised 29.03.2024 published: Print Citation Status MEDLINE |
---|
doi: |
10.1093/cid/ciad447 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM363245561 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM363245561 | ||
003 | DE-627 | ||
005 | 20240331000714.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1093/cid/ciad447 |2 doi | |
028 | 5 | 2 | |a pubmed24n1357.xml |
035 | |a (DE-627)NLM363245561 | ||
035 | |a (NLM)37831591 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Rhee, Chanu |e verfasserin |4 aut | |
245 | 1 | 0 | |a Improving Sepsis Outcomes in the Era of Pay-for-Performance and Electronic Quality Measures |b A Joint IDSA/ACEP/PIDS/SHEA/SHM/SIDP Position Paper |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 22.03.2024 | ||
500 | |a Date Revised 29.03.2024 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com. | ||
520 | |a The Centers for Medicare & Medicaid Services (CMS) introduced the Severe Sepsis/Septic Shock Management Bundle (SEP-1) as a pay-for-reporting measure in 2015 and is now planning to make it a pay-for-performance measure by incorporating it into the Hospital Value-Based Purchasing Program. This joint IDSA/ACEP/PIDS/SHEA/SHM/SIPD position paper highlights concerns with this change. Multiple studies indicate that SEP-1 implementation was associated with increased broad-spectrum antibiotic use, lactate measurements, and aggressive fluid resuscitation for patients with suspected sepsis but not with decreased mortality rates. Increased focus on SEP-1 risks further diverting attention and resources from more effective measures and comprehensive sepsis care. We recommend retiring SEP-1 rather than using it in a payment model and shifting instead to new sepsis metrics that focus on patient outcomes. CMS is developing a community-onset sepsis 30-day mortality electronic clinical quality measure (eCQM) that is an important step in this direction. The eCQM preliminarily identifies sepsis using systemic inflammatory response syndrome (SIRS) criteria, antibiotic administrations or diagnosis codes for infection or sepsis, and clinical indicators of acute organ dysfunction. We support the eCQM but recommend removing SIRS criteria and diagnosis codes to streamline implementation, decrease variability between hospitals, maintain vigilance for patients with sepsis but without SIRS, and avoid promoting antibiotic use in uninfected patients with SIRS. We further advocate for CMS to harmonize the eCQM with the Centers for Disease Control and Prevention's (CDC) Adult Sepsis Event surveillance metric to promote unity in federal measures, decrease reporting burden for hospitals, and facilitate shared prevention initiatives. These steps will result in a more robust measure that will encourage hospitals to pay more attention to the full breadth of sepsis care, stimulate new innovations in diagnosis and treatment, and ultimately bring us closer to our shared goal of improving outcomes for patients | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a SEP-1 | |
650 | 4 | |a quality measures | |
650 | 4 | |a sepsis | |
650 | 4 | |a sepsis bundle | |
650 | 4 | |a septic shock | |
650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
700 | 1 | |a Strich, Jeffrey R |e verfasserin |4 aut | |
700 | 1 | |a Chiotos, Kathleen |e verfasserin |4 aut | |
700 | 1 | |a Classen, David C |e verfasserin |4 aut | |
700 | 1 | |a Cosgrove, Sara E |e verfasserin |4 aut | |
700 | 1 | |a Greeno, Ron |e verfasserin |4 aut | |
700 | 1 | |a Heil, Emily L |e verfasserin |4 aut | |
700 | 1 | |a Kadri, Sameer S |e verfasserin |4 aut | |
700 | 1 | |a Kalil, Andre C |e verfasserin |4 aut | |
700 | 1 | |a Gilbert, David N |e verfasserin |4 aut | |
700 | 1 | |a Masur, Henry |e verfasserin |4 aut | |
700 | 1 | |a Septimus, Edward J |e verfasserin |4 aut | |
700 | 1 | |a Sweeney, Daniel A |e verfasserin |4 aut | |
700 | 1 | |a Terry, Aisha |e verfasserin |4 aut | |
700 | 1 | |a Winslow, Dean L |e verfasserin |4 aut | |
700 | 1 | |a Yealy, Donald M |e verfasserin |4 aut | |
700 | 1 | |a Klompas, Michael |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |d 1992 |g 78(2024), 3 vom: 20. März, Seite 505-513 |w (DE-627)NLM012603007 |x 1537-6591 |7 nnns |
773 | 1 | 8 | |g volume:78 |g year:2024 |g number:3 |g day:20 |g month:03 |g pages:505-513 |
856 | 4 | 0 | |u http://dx.doi.org/10.1093/cid/ciad447 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 78 |j 2024 |e 3 |b 20 |c 03 |h 505-513 |